(Q44839223)
Statements
The impact of patient and tumour baseline characteristics on the overall survival of patients with advanced hepatocellular carcinoma treated with sorafenib (English)
Marcus A Wörns
Sandra Koch
Ina M Niederle
Marc Nguyen-Tat
Thomas Gamstätter
Marcus Schuchmann
Henning Schulze-Bergkamen
21 November 2012